by admin | Sep 14, 2015 | Latest News
Hatchtech is the third successful exit for Uniseed since May 2014 Deal follows recent Uniseed exits of Spinifex in June 2015 (US$700m total deal value) and Fibrotech in May 2014 (US$557m total deal value) Hatchtech deal represents potential returns to Uniseed of up to...
by admin | Sep 11, 2015 | Latest News
Spinifex Pharmaceuticals Pty Ltd was awarded the Australian Venture Capital Association (AVCAL) Best Early Stage Deal at last night’s awards in Melbourne. In June, Spinifex reached an agreement with Novartis International AG, under which Novartis purchased Spinifex...
by admin | Sep 1, 2015 | Latest News
In this newsletter we talk about two of our investees: Hatchtech and Dr. Reddy’s Laboratories sign US$197 million commercial agreement for next generation head lice treatment Uniseed investee ProGel Pty Ltd releases Perkii® probiotic drink. ...
Recent Comments